Skip to main content
Premium Trial:

Request an Annual Quote

True Health Dx Set to Buy HDL's Assets for $37.1M

NEW YORK (GenomeWeb) – Health Diagnostic Laboratory today said that True Health Diagnostics submitted a successful bid of $37.1 million to acquire substantially all of HDL's assets. 

Richmond, Virginia-based HDL is in Chapter 11 bankruptcy protection, and last week True Health submitted a "stalking horse bid" of $32 million to acquire the firm's assets. During an auction proceeding on Thursday, the Frisco, Texas-based diagnostics firm increased its offer to beat out bids from other interested buyers, HDL said.

The sale is subject to final approval by US Bankruptcy Court. A Sept. 16 hearing on the matter has been scheduled, and the deal is anticipated to be completed by the end of the month. 

True Health CEO Chris Grottenthaler said in a statement that HDL's business "aligns perfectly with ours." His firm will retain "hundreds" of HDL's employees, he added. 

HDL filed for Chapter 11 protection in June shortly after reaching an agreement with the US Department of Justice to settle an investigation into whether HDL's payments to doctors were essentially kickbacks to encourage them to order the firm's tests. HDL agreed to pay nearly $50 million as part of the settlement but denied wrongdoing.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.